Triple-Negative and Basal-Like Breast Cancer: Implications for Oncologists
1
Department of Pathology, McGill University, Montreal, QC, Canada
2
Program in Cancer Genetics and Departments of Oncology and of Human Genetics, McGill University, Montreal, QC, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2011, 18(4), 161-164; https://doi.org/10.3747/co.v18i4.824
Submission received: 2 May 2011
/
Revised: 3 June 2011
/
Accepted: 4 July 2011
/
Published: 1 August 2011
Excerpt
Note: In lieu of an abstract, this is an excerpt from the first page.
Since the start of the 1990s, molecular pathology has been playing an increasingly important role in cancer diagnosis and treatment.[...]
Share and Cite
MDPI and ACS Style
Lachapelle, J.; Foulkes, W.D. Triple-Negative and Basal-Like Breast Cancer: Implications for Oncologists. Curr. Oncol. 2011, 18, 161-164. https://doi.org/10.3747/co.v18i4.824
AMA Style
Lachapelle J, Foulkes WD. Triple-Negative and Basal-Like Breast Cancer: Implications for Oncologists. Current Oncology. 2011; 18(4):161-164. https://doi.org/10.3747/co.v18i4.824
Chicago/Turabian StyleLachapelle, J., and W.D. Foulkes. 2011. "Triple-Negative and Basal-Like Breast Cancer: Implications for Oncologists" Current Oncology 18, no. 4: 161-164. https://doi.org/10.3747/co.v18i4.824
